CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 2	2026-03-27		NCT05260528

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Acute Leukemia French Association	5
Centre Hospitalier Universitaire de Nice	229
Jazz Pharmaceuticals	60

35 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Centre Antoine Lacassagne	Nice	France	60
Centre Henri Becquerel	Rouen	France	71
Centre Hospitalier de Béziers	Béziers	France	3
Centre Hospitalier de Versailles, Site André Mignot	Le Chesnay	France	1
Centre Hospitalier Sud Francilien (CHSF)	Corbeil-Essonnes	France	1
CH Avignon	Avignon	France	4
CH de Roubaix	Roubaix	France	3
CHR Metz-Thionville Site Mercy	Metz	France	1
CHR Orléans	Orléans	France	9
CHRU Jean Minjoz	Besançon	France	11
CHU Amiens Picardie site Sud	Amiens	France	2
CHU d'Angers	Angers	France	27
CHU de Bordeaux	Pessac	France	5
CHU de Limoges	Limoges	France	30
CHU de Nantes	Nantes	France	60
CHU de Nice	Nice	France	51
CHU de Saint Etienne	Saint-Priest-en-Jarez	France	3
CHU de Toulouse	Toulouse	France	42
Chu Estaing	Clermont-Ferrand	France	18
CHU Henri Mondor	Créteil	France	18
Groupe hospitalier de la région de Mulhouse et Sud-Alsace, Hôpital Emile Muller	Mulhouse	France	1
Hopital Bretonneau	Tours	France	4
Hopital Lyon Sud	Pierre-Bénite	France	2
Hopital Necker	Paris	France	9
Hoptial de la Conception APHM	Marseille	France	1

Clinical trials